Shkreli-Tied Pharma Co. Cleared For $650K Ch. 11 Sale
A bankrupt pharmaceutical company tied to convicted securities fraudster Martin Shkreli received court approval Wednesday for a $650,000 sale of its parasite-treating Daraprim assets, but confirmation of its Chapter 11 plan...To view the full article, register now.
Already a subscriber? Click here to view full article